Introduction
============

Pain is one of the most feared aspects for patients diagnosed with cancer. In the majority of cases, oral opioids and adjuvant therapy are sufficient in treating this pain. Unfortunately, a small percentage of patients do not respond to conservative management and must undergo interventional procedures to maximize their pain relief. Some techniques used in the management of cancer-related pain include neurolytic blocks as well as spinal and epidural analgesia. Spinal analgesia is the delivery of agents such as opioids and local anesthetics to the cerebrospinal fluid (CSF) usually via an implanted catheter and pump system. This is a very effective method for pain control but can be difficult to manage and titrate in an outpatient setting. Epidural analgesia via a catheter is also an effective system and more likely to be used when the life expectancy of the patient is less than 3 months, secondary to cost considerations. One particular problem is unilateral epidural analgesia from the uneven distribution of local anesthetic in the epidural space which has been described in the literature. The combination of a misplaced catheter with contributing secondary causes such as small volumes of injectate, a dorsomedian septum (plica mediana dorsalis \[PMD\]), or even disruption of the PMD through high pressure injection or the epidural needle may affect the restriction of epidural spread and change the likelihood of a unilateral spread of local anesthetic.[@b1-lra-10-079]--[@b4-lra-10-079] Many non-uniform distributions of contrast have been shown to produce bilateral analgesia. [@b2-lra-10-079],[@b3-lra-10-079] What is certain is that the epidural space is not uniform throughout and it can often have significant variability which can create a signifi-cant challenge in obtaining effective epidural analgesia.[@b2-lra-10-079]--[@b5-lra-10-079] Here we present a case requiring the use of bilateral epidural catheters in order to achieve bilateral analgesia.

Case report
===========

A 55-year-old Caucasian female with stage IV pancreatic cancer and without other significant medical history presented to the interventional pain clinic with increasing sacral, lower extremity, and pelvic pain. The patient was unable to ambulate secondary to pain and deconditioning. Magnetic resonance imaging without contrast and computed tomography (CT) with contrast just prior to her clinic visit showed a large pancreatic mass with liver infiltration, multiple pelvic and sacral metastatic lesions, and a significant collection of intra-abdominal fluid. Of note, the lumbar and sacral epidural space showed no abnormalities or lesions. Her oncology team determined she was no longer a candidate for any further treatment and recommended palliative measures only. Her prognosis was poor with a life expectancy of a few weeks. Her pain control regimen included fentanyl patch 200 mcg every 72 hours, hydrocodone/acetaminophen 10/325 mg every 6 hours as needed, duloxetine 60 mg daily, and gabapentin 300 mg three times a day; however, she continued to have uncontrolled pain with significant decrease in her quality of life.

Due to the patient's poor prognosis and short life expectancy, an implantable intrathecal pain pump was not pursued. It was decided that a tunneled multiorifice epidural catheter with an external infusion pump would be the best treatment option for her pain. The epidural catheter was placed at the L5-S1 level using standard fluoroscopic technique. A paramedian approach with the Tuohy bevel directed cephalad was used to advance the catheter to the L3--4 vertebral level. Then 2 mL of injected contrast showed spread along the right L5 and S1 nerve roots. There was no contralateral spread seen ([Figure 1](#f1-lra-10-079){ref-type="fig"}) and therefore the decision was made to inject a test dose of 6 mL of bupivacaine 0.25%. After waiting for 10 minutes, the patient was assessed and she had marked anesthesia and decreased pain on her right side, but normal pain on the left. To get full relief of her symptoms, it was decided to place a second tunneled epidural catheter using the same technique as the previous catheter placement along the left side of the epidural space at the same L5-S1 level in order to achieve bilateral analgesia. Then 2 mL of contrast was again injected through this catheter after placement, and it showed spread only along the left L5 and S1 nerve roots ([Figure 2](#f2-lra-10-079){ref-type="fig"}). To achieve contrast spread bilaterally, injection through both epidural catheters was required. The placement of two epidural catheters was therefore performed in order to avoid the anticipated poor bilateral spread of infused local anesthetic and subsequent inadequate pain relief. The patient tolerated the procedure well and was placed on dual patient controlled epidural analgesia (PCEA) pumps with each pump delivering a basal dose of 3 mL of bupivacaine 0.2% per hour with a demand dose of 3 mL every 30 minutes. She received excellent pain control and her reported numeric pain score for her lower extremity and sacral pain went from a 10 to a 3. She was discharged to hospice and placed under the care of the palliative physician. On phone call follow-up, it was reported that she had no adverse effects associated with the epidural infusion and continued to have numeric pain scores in the 3 to 6 range. While in hospice she was continued on the same basal epidural infusion and with approximately five demand doses per day. The patient remained on the same topical and oral pain medication regimen, which included transdermal fentanyl and oral hydrocodone/acetaminophen. Unfortunately after 4 weeks, the patient passed away in her sleep with her husband at her bedside. Written informed consent was obtained from the patient's next of kin (husband) to publish this case report and any accompanying images.

Discussion
==========

Although unilateral epidural analgesia is relatively rare, we must be aware of its possibility and adapt our decision making appropriately. This is an especially important consideration to achieve the best outcomes for patients with cancer-related pain. There have been many proposed mechanisms for the uneven distribution of local anesthetic causing unilateral analgesia including slow injection of small volumes of local anesthetic, acquired adhesions in the epidural space, misplacement of the catheter in the epidural space, and a dorsomedian septum in the lumbar epidural space.[@b1-lra-10-079],[@b6-lra-10-079]--[@b9-lra-10-079] A substantial amount of disagreement still surrounds the hypothesis that a PMD often exists in the epidural space and that it clinically affects local anesthetic spread. Previous case reports have described unilateral analgesia associated with partitioning within the epidural space confirmed through imaging.[@b7-lra-10-079],[@b10-lra-10-079],[@b11-lra-10-079] The existence of PMD and its prevention of bilateral spread of contrast in the lumbar epidural space have been demonstrated using CT with contrast and epidurography.[@b1-lra-10-079],[@b5-lra-10-079],[@b12-lra-10-079],[@b13-lra-10-079] However, CT scans without contrast and histologic examinations have often failed to determine the composition of the PMD as no fibrous fold or septum was found in the epidural space.[@b1-lra-10-079]--[@b4-lra-10-079],[@b14-lra-10-079] Alternatively, it has been proposed that the makeup of the structures in the epidural space is actually adipose tissue collections which are distorted by injectate and that any unilateral spread is most likely due to needle and catheter misplacement.[@b2-lra-10-079],[@b3-lra-10-079] Regardless of its composition, it is important to note that a PMD may not be the most important or only factor responsible for unilateral spread of local anesthetic.

The patient had intractable neoplasm-related sacral and pelvic pain secondary to compression and inflammation of nerves by tumors. Using dual epidural catheters with PCEA proved to be an effective and necessary technique in this patient to achieve bilateral analgesia. The decision to place bilateral epidural catheters was made only after ruling out malposition of the catheter and using a large volume test dose to confirm persistent unilateral analgesia. The advantages to the epidural analgesia technique include a proven history for the effectiveness for terminal cancer pain, the ability to confirm bilateral analgesia prior to the patient leaving the procedure room, and the ability to titrate dosing to maximize analgesia and minimize side effects. Disadvantages to placing two external catheters are that there is a potential increased risk of infection and complications associated with placement when compared to using a single catheter. Alternatives to this procedure could include a single intrathecal phenol ablation of spinal nerves or increasing oral opiate dosing. Another option could have been to remove the epidural catheter and replace it with a single intrathecal catheter for a direct infusion of analgesics into the CSF. Some limitations of these techniques include possible elimination of motor function and higher chance of intolerability of opiate side effects. Ultimately the patient received effective pain control for the remainder of her life. The dual epidural catheter technique for controlling terminal cancer pain should be considered in patients who receive insufficient analgesia from oral opioid and other palliative treatments.

The abstract of this paper was presented as a poster presentation at the North American Neuromodulation Society Annual Conference 2017.[@b15-lra-10-079]
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